Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no cure and limited treatment options.
New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI ...
A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...
IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...
A newly published study says that the body’s own immune system may be responsible for driving the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig’s disease. Scientists ...
A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...
Please provide your email address to receive an email when new articles are posted on . A new analysis of an overall survival study of an investigational immunotherapy platform to treat ALS found it ...
A new study from Sweden found long-term exposure to air pollution is linked to an increased risk of ALS and worse outcomes ...
The drug targets a specific mutation that applies to only 2% of ALS patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results